XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
  X Chromosome
  Genetic Disorders
  Cloning
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
 
 India
Search

Last Updated: Nov 18, 2006 - 12:32:53 PM

Genetics Channel
subscribe to Genetics newsletter

Latest Research : Genetics

   DISCUSS   |   EMAIL   |   PRINT
Research points to possible therapy to prevent congenital skull malformation
Dec 25, 2005 - 12:56:00 AM, Reviewed by: Dr. Priya Saxena

"If you knock out this gene in every single cell in the body, the embryos die very early. That doesn't help us figure out the role the gene plays in cranial development"

 
Craniofacial researchers have developed an animal model that explains how skull malformations occur and how they might be prevented.

Birth defects of the face and skull are relatively common in humans, striking one in 500 to 1,000 babies. Defects can include cleft lip or palate, congenitally missing teeth and severe malformations of the skull.

A group led by Yang Chai, chair of the division of craniofacial sciences and therapeutics in the USC School of Dentistry, has identified the genetic factor leading to malformation of the forehead and frontal part of the skull. The discovery was published online Dec. 20 by the journal Development.

Children with frontal bone defects lack vital protection for their brain. They also may develop bulging, irregularly shaped heads.

Chai's group focused on a gene called transforming growth factor- beta. TGF-beta is known to play an important role in human and animal development.

To study the gene's effect on the skull, the researchers deleted TGF-beta in mice embryos, but only in the cranial neural crest cells that build facial bone and cartilage.

"If you knock out this gene in every single cell in the body, the embryos die very early. That doesn't help us figure out the role the gene plays in cranial development," Chai said.

The rest of the embryo's cells were allowed to retain the gene and grew normally.

Mice born from the treated embryos carried severe craniofacial defects, including cleft palate and skull malformations.

The results showed that TGF-beta is necessary for proper development of frontal bones.

In addition, the researchers found that they could rehabilitate embryos with missing TGF-beta by inoculating them with FGF, an intermediate protein in the "signaling cascade" that starts with TGF-beta and ends with healthy facial structures.

Chai's group concluded that TGF-beta acts through FGF to ensure proper development. This suggests a potential therapy for embryos that are missing TGF-beta in the neural crest cells.

"This might be useful to try out some possible rescue experiments," Chai said.

Although Chai's current results apply only to mice, a paper last spring in Nature Genetics (Loeys et al., 2005) identified a handful of human families with inherited mutations in TGF-beta receptors and with a high incidence of craniofacial defects, including cleft palate and skull malformations.

If the signaling mechanism in mice were to carry over to humans, pharmaceutical researchers could start to investigate FGF as a potential supplement for pregnant women, analogous to folic acid for prevention of spina bifida.

Chai noted that the FGF supplements in mice restored normal cell growth only in the skull region.

"Using FGF signaling we can actually rescue the cell proliferation defect, but so far we have not been able to do the same thing in the palate," Chai said.

TGF-beta also appears to work through different mechanisms in other parts of the body, Chai added. This suggests that no single treatment can correct all birth defects related to TGF-beta.
 

- The discovery was published online Dec. 20 by the journal Development
 

www.usc.edu

 
Subscribe to Genetics Newsletter
E-mail Address:

 

This research was supported by a grant from the National Institute of Dental and Craniofacial Research.

Related Genetics News

New research into csd genes could help designing strategies for breeding honey bees
Williams Syndrome, the brain and music
Genetic mutation identified as cause of cranio-lenticulo-sutural dysplasia
Chance Fluctuations in mRNA Output in Mammalian Cells
Transposon Silencing Keeps Jumping Genes in Their Place
GATA2 - predicting susceptibility to coronary artery disease
Exploring genetics of congenital malformations
Genome insertions and deletions (INDELs) provide expanded view of human genetic differences
BRIT1 gene identified as protector of DNA
FDA Approves Idursulfase As First Treatment for Hunter Syndrome


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us